Adjuvant nivolumab monotherapy vs placebo for localized renal cell carcinoma at high risk of relapse after nephrectomy: Results from Part B of the randomized, phase 3 CheckMate 914 trial.

Autor: Motzer, Robert J., Bex, Axel, Russo, Paul, Tomita, Yoshihiko, Cutuli, Hernan, Rojas, Carlos, Gross-Goupil, Marine, Schinzari, Giovanni, Melichar, Bohuslav, Barthelemy, Philippe, Ruiz Garcia, Abraham, Sosman, Jeffrey A., Grimm, Marc-Oliver, Goh, Jeffrey C., Suárez, Cristina, Kollmannsberger, Christian K., Simsek, Burcin, Spiridigliozzi, Julia, Lee, Chung-Wei, Grünwald, Viktor
Zdroj: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pLBA358-LBA358, 6p
Databáze: Supplemental Index